Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 6/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31451422 | 0.85 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL4941786 | 0.79 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL25243087 | 0.79 | HDAC3 (0.53) | L3MBTL1ALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL4944588 | 0.76 | HDAC3 (0.60) | L3MBTL1ALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL11613018 | 0.76 | L3MBTL1 (0.64) | L3MBTL1ALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL1001108 | 0.73 | L3MBTL1 (0.78) | L3MBTL1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL751185 | 0.73 | L3MBTL1 (0.65) | L3MBTL1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL4945434 | 0.73 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL3101917 | 0.73 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL19700183 | 0.73 | L3MBTL1 (0.56) | L3MBTL1ALDH1A1HPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080045534-A1 | Derivatives of 1,3-diamino benzene as potassium channel modulators | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045534-A1 | Derivatives of 1,3-diamino benzene as potassium channel modulators | KCNQ1, KCNQ2, KCNA1 | L3MBTL1 4175/4885ALDH1A1 718/4885LMNA 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.